Tag: NCT03401788

Home / NCT03401788

Categories

Belzutifan has been approved by the FDA for malignancies linked to von Hippel-Lindau disease

August 2021: Belzutifan (Welireg, Merck), a hypoxia-inducible factor inhibitor, has been approved by the Food and Drug Administration for adult patients with von Hippel-Lindau disease who require ther...
nct03401788

Scan the code